Form D · Other Health Care
Arix Bioscience plc
London, X0 · CIK 0001700449
Offering snapshot reported Apr 4, 2018 · SEC filing
- Reported sold
- $21.4M Offering amount: $122M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 20, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2018 | Initial | $21,438,354 | No comparison | 5 | SEC filing |
| Mar 13, 2017 | Amendment | $17,943,967 | $437,003vs Mar 9, 2017 | 4 | SEC filing |
| Mar 9, 2017 | Initial | $17,506,964 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $379K
- Finders' fees
- $0
- Form D file number
- 021-309307
Offering was conducted as a public offering in the U.K. and available to U.S. investors by private placement. Offering raised approx. $121,778,626 in total, with approx. $21,438,354 raised in the U.S. and approx. $100,340,272 raised outside the U.S.
Sales commissions were paid to Jeffries, Stifel and LifeSci in the amounts of approx. $279,522, $65,139, and $34,466, respectively.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| JEFFRIES INTERNATIONAL LIMITED | None | JEFFRIES & COMPANY, INC. · CRD 2347 |
| STIFEL NICOLAUS EUROPE LIMITED | None | STIFEL, NICOLAUS & COMPANY, INCORPORATED · CRD 793 |
| LIFESCI CAPITAL LLC | 168404 |
Source: Form D, filed Apr 4, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Anderson | Director, Executive |
| John Banham | Director |
| Christopher Evans | Director, Executive |
| Meghan Mair Fitzgerald | Director |
| Franz Humer | Director |
| John Hutton Of Furness | Director |
| Trevor Jones | Director |
| Giles Kerr | Director |
| John Mutton Of Furness | Director |
| Jonathan Peacock | Director, Executive |
| James Rawlingson | Director, Executive |
| David U'prichard | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
20 Berkeley Square
London, X0, W1J 6EQ
London, X0, W1J 6EQ